Glycomic biomarkers are instrumental for suboptimal health status management in the context of predictive, preventive, and personalized medicine.

Meng, Xiaoni; Wang, Biyan; Xu, Xizhu; Song, Manshu; Hou, Haifeng; Wang, Wei; Wang, Youxin

Meng, Xiaoni; Wang, Biyan; Xu, Xizhu; Song, Manshu; Hou, Haifeng; Wang, Wei; Wang, Youxin.

Afiliación

Meng X; Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, 10 Youanmen, Fengtai District, Beijing, 100069 China.
Wang B; Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, 10 Youanmen, Fengtai District, Beijing, 100069 China.
Xu X; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, China.
Song M; Centre for Precision Health, Edith Cowan University, Perth, Australia.
Hou H; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, China.
Wang W; Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, 10 Youanmen, Fengtai District, Beijing, 100069 China.
Wang Y; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, China.

EPMA J ; 13(2): 195-207, 2022 Jun.

Article en En | MEDLINE | ID: mdl-35719133

Palabras clave

Biomarkers; Glycomics; IgG N-glycosylation; Predictive preventive personalized medicine (PPPM/3PM); Suboptimal health status

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: EPMA J Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google